Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications

Bhupendra      Dixena; Rashmi      Madhariya; Anupama      Panday; Alpana      Ram; Akhlesh   K.   Jain
doi:10.2174/0115672018272012231213100535
Abstract

Background: Transdermal drug delivery systems (TDDS) offer several advantages over traditional methods such as injections and oral administration. These advantages include preventing first-pass metabolism, providing consistent and sustained activity, reducing side effects, enabling the use of short half-life drugs, improving physiological response, and enhancing patient convenience. However, the permeability of skin poses a challenge for TDDS, as it is impermeable to large molecules and hydrophilic drugs but permeable to small molecules and lipophilic drug. To overcome this barrier, researchers have investigated vesicular systems, such as transfersomes, liposomes, niosomes, and ethosomes. Among these vesicular systems, transfersomes are particularly promising for noninvasive drug administration due to their deformability and flexible membrane. They have been extensively studied for delivering anticancer drugs, insulin, corticosteroids, herbal medicines, and NSAIDs through the skin. Transfersomes have demonstrated efficacy in treating skin cancer, improving insulin delivery, enhancing site-specific corticosteroid delivery, and increasing the permeation and therapeutic effects of herbal medicines. They have also been effective in delivering pain relief with minimal side effects using NSAIDs and opioids. Transfersomes have been used for transdermal immunization and targeted drug delivery, offering site-specific release and minimizing adverse effects. Overall, transfersomes are a promising approach for transdermal drug delivery in various therapeutic applications.
Objective: The aim of the present review is to discuss the various advantages and limitations of transfersomes and their mechanism to penetration across the skin, as well as their application for the delivery of various drugs like anticancer, antidiabetic, NSAIDs, herbal drugs, and transdermal immunization.
Methods: Data we searched from PubMed, Google Scholar, and ScienceDirect.
Results: In this review, we have explored the various methods of preparation of transfersomes and their application for the delivery of various drugs like anticancer, antidiabetic, NSAIDs, herbal drugs, and transdermal immunization.
Conclusion: In comparison to other vesicular systems, transfersomes are more flexible, have greater skin penetration capability, can transport systemic medicines, and are more stable. Transfersomes are capable of delivering both hydrophilic and hydrophobic drugs, making them suitable for transdermal drug delivery. The developed transfersomal gel could be used to improve medicine delivery through the skin.
Keywords: Transfersomes, drug delivery, insulin, edge activator, transdermal immunization, ligand conjugated transfersomes, herbal drugs.
« Previous Next »
Graphical Abstract

[1]
Jeong, W.Y.; Kwon, M.; Choi, H.E.; Kim, K.S. Recent advances in transdermal drug delivery systems: A review. Biomater. Res.,  2021, 25(1), 24.
 [http://dx.doi.org/10.1186/s40824-021-00226-6] [PMID:  34321111]

[2]
Bhowmik, D.; Kumar, K.S.; Bhanot, R. Recent advances in transdermal drug delivery system; LAP Lambert Academic Publishing, 2017. 

[3]
Chaurasiya, P.; Ganju, E.; Upmanyu, N.; Ray, S.K.; Jain, P. Transfersomes: A novel technique for transdermal drug delivery. J. Drug Deliv. Ther.,  2019, 9(1), 279-285.
 [http://dx.doi.org/10.22270/jddt.v9i1.2198]

[4]
Trommer, H.; Neubert, R.H.H. Overcoming the stratum corneum: The modulation of skin penetration. A review. Skin Pharmacol. Physiol.,  2006, 19(2), 106-121.
 [http://dx.doi.org/10.1159/000091978] [PMID:  16685150]

[5]
Touitou, E.; Junginger, H.E.; Weiner, N.D.; Nagai, T.; Mezei, M. Liposomes as carriers for topical and transdermal delivery. J. Pharm. Sci.,  1994, 83(9), 1189-1203.
 [http://dx.doi.org/10.1002/jps.2600830902] [PMID:  7830230]

[6]
Barry, B.W. Breaching the skin’s barrier to drugs. Nat. Biotechnol.,  2004, 22(2), 165-167.
 [http://dx.doi.org/10.1038/nbt0204-165] [PMID:  14755286]

[7]
Raj, A. C, S.C.; v, A.N.; Ivon, A.; M, N.F.N.; P, N.N.P. Lipid-based vesicles: A non-invasive tool for transdermal drug delivery. J. Pharm. Innov.,  2022, 17(3), 1039-1052.
 [http://dx.doi.org/10.1007/s12247-021-09572-3]

[8]
Xu, X.; Khan, M.A.; Burgess, D.J. Predicting hydrophilic drug encapsulation inside unilamellar liposomes. Int. J. Pharm.,  2012, 423(2), 410-418.
 [http://dx.doi.org/10.1016/j.ijpharm.2011.12.019] [PMID:  22207162]

[9]
Singh, D.; Pradhan, M.; Nag, M.; Singh, M.R. Vesicular system: Versatile carrier for transdermal delivery of bioactives. Artif. Cells Nanomed. Biotechnol.,  2015, 43(4), 282-290.
 [http://dx.doi.org/10.3109/21691401.2014.883401] [PMID:  24564350]

[10]
Langer, R. Transdermal drug delivery: Past progress, current status, and future prospects. Adv. Drug Deliv. Rev.,  2004, 56(5), 557-558.
 [http://dx.doi.org/10.1016/j.addr.2003.10.021] [PMID:  15019745]

[11]
Solanki, D.; Kushwah, L.; Motiwale, M.; Chouhan, V. Transferosomes-a review. World J. Pharm. Pharm. Sci.,  2016, 5(10), 435-449.

[12]
Fernández-García, R.; Lalatsa, A.; Statts, L.; Bolás-Fernández, F.; Ballesteros, M.P.; Serrano, D.R. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. Int. J. Pharm.,  2020, 573, 118817.
 [http://dx.doi.org/10.1016/j.ijpharm.2019.118817] [PMID:  31678520]

[13]
Sachan, R.; Parashar, T.; Soniya, S.V.; Singh, G.; Tyagi, S.; Patel, C. Drug carrier transfersomes: A novel tool for transdermal drug delivery system. Inter. J. Res. Deve. Pharma. Life Sci.,  2013, 2(2), 309-316.

[14]
Sivannarayana, P.; Rani, A.P.; Saikishore, V. Transfersomes: Ultra deformable vesicular carrier systems in transdermal drug delivery system. Res. J. Pharm. Dos. Forms Technol.,  2012, 4(5), 243-255.

[15]
Sarmah, P.J.; Kalita, B.; Sharma, A.K. Transfersomes based transdermal drug delivery: An overview. Int J Adv Pharm Res.,  2013, 4(12), 2555-2563.

[16]
Pandey, M.; Choudhury, H.; Gorain, B.; Tiong, S.Q.; Wong, G.Y.S.; Chan, K.X.; They, X.; Chieu, W.S. Site-specific vesicular drug delivery system for skin cancer: A novel approach for targeting. Gels,  2021, 7(4), 218.
 [http://dx.doi.org/10.3390/gels7040218] [PMID:  34842689]

[17]
Akram, M.W.; Jamshaid, H.; Rehman, F.U.; Zaeem, M. Khan Jz, Zeb A. Transfersomes: A revolutionary nanosystem for efficient transdermal drug delivery. AAPS PharmSciTech,  2022, 23, 1-18.

[18]
Opatha, S.A.T.; Titapiwatanakun, V.; Chutoprapat, R. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics,  2020, 12(9), 855.
 [http://dx.doi.org/10.3390/pharmaceutics12090855] [PMID:  32916782]

[19]
Thakur, L.; Ghodasra, U.; Patel, N.; Dabhi, M. Novel approaches for stability improvement in natural medicines. Pharmacogn. Rev.,  2011, 5(9), 48-54.
 [http://dx.doi.org/10.4103/0973-7847.79099] [PMID:  22096318]

[20]
Vinod, K.R.; Kumar, M.S.; Anbazhagan, S.; Sandhya, S.; Saikumar, P.; Rohit, R.T.; Banji, D. Critical issues related to transfersomes - novel vesicular system. Acta Sci. Pol. Technol. Aliment.,  2012, 11(1), 67-82.
 [PMID:  22230977]

[21]
Jiang, T.; Wang, T.; Li, T.; Ma, Y.; Shen, S.; He, B.; Mo, R. Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma. ACS Nano,  2018, 12(10), 9693-9701.
 [http://dx.doi.org/10.1021/acsnano.8b03800] [PMID:  30183253]

[22]
Modi, C.; Bharadia, P. Transfersomes: New dominants for transdermal drug delivery. Am J Pharm Tech Res.,  2012, 2(3), 71-91.

[23]
Walve, J; Bakliwal, S; Rane, B; Pawar, S. Transfersomes: A surrogated carrier for transdermal drug delivery system.,  2011, 2(1)

[24]
Jain, S.; Umamaheswari, R.; Bhadra, D.; Tripathi, P.; Jain, P.; Jain, N. Ultradeformable liposomes: A recent tool for effective transdermal drug delivery. Indian J. Pharm. Sci.,  2003, 65(3), 223-231.

[25]
El Zaafarany, G.M.; Awad, G.A.S.; Holayel, S.M.; Mortada, N.D. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int. J. Pharm.,  2010, 397(1-2), 164-172.
 [http://dx.doi.org/10.1016/j.ijpharm.2010.06.034] [PMID:  20599487]

[26]
Jain, A.K.; Kumar, F. Transfersomes: Ultradeformable vesicles for transdermal drug delivery. Asian J Biomater Res.,  2017, 3, 1-3.

[27]
Kumar, P.K.; Kumar, R.S. Review on transferosomes and transferosomal gels. J. Pharm. Res. Int.,  2021, 33(43B), 114-126.
 [http://dx.doi.org/10.9734/jpri/2021/v33i43B32532]

[28]
Kurhe, S.A.; Bavaskar, K.; Jain, A. Transferosome: A vesicular transdermal delivery system for enhanced drug permeation. J. Adv. Pharm. Technol. Res.,  2022, 2(3), 138-143.

[29]
Li, J.; Wang, X.; Zhang, T.; Wang, C.; Huang, Z.; Luo, X. A review on phospholipids and their main applications in drug delivery systems. Asian J. Pharma. Sci.,  2015, 10(2), 81-98.
 [http://dx.doi.org/10.1016/j.ajps.2014.09.004]

[30]
Singh, S.R. Transferosme: A novel approach for transdermal drug delivery system. Intern. J. Pharma. Res.,  2016, 8(3)

[31]
Caritá, A.C.; Resende de Azevedo, J.; Chevalier, Y.; Arquier, D.; Buri, M.V.; Riske, K.A.; Ricci Leonardi, G.; Bolzinger, M.A. Elastic cationic liposomes for vitamin C delivery: Development, characterization and skin absorption study. Int. J. Pharm.,  2023, 638, 122897.
 [http://dx.doi.org/10.1016/j.ijpharm.2023.122897] [PMID:  37003313]

[32]
Tyagi, S; Prabhakar Vishvakarma, DMUI Recent advancement and prospective of nanocarriers like ethosome, liposome, transferosome for therapeutic applications with topical drug delivery system.,  Available from: https://www.eurchembull.com/uploads/paper/1dbe7b70b6a37fe5a44596d6d999516b.pdf

[33]
Abd El-Alim, S.H.; Kassem, A.A.; Basha, M.; Salama, A. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation. Int. J. Pharm.,  2019, 563, 293-303.
 [http://dx.doi.org/10.1016/j.ijpharm.2019.04.001] [PMID:  30951860]

[34]
Ghanbarzadeh, S.; Arami, S. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed Res. Int.,  2013, 2013, 1-7.
 [http://dx.doi.org/10.1155/2013/616810] [PMID:  23936825]

[35]
Kumar, R.; Singh, M.; Bala, R.; Seth, N.; Rana, A. Transferosomes: A novel approach for transdermal drug delivery. International Research Journal of Pharmacy.,  2012, 3(1), 20-24.

[36]
Patel, S.; Patel, N.; Patel, K.; Patel, N. A Vesicular Transdermal delivery system for enhance drug Permeation-Ethosomes & Transferosomes. Internationale Pharmaceutica Sciencia.,  2012, 2(2), 24-34.

[37]
Kumar, VD; Saraswathi, B Kanth NPJIJoPS, Research. Transferosome: latest updates.,  2013, 4(11), 4125.

[38]
Gupta, A; Aggarwal, G; Singla, S Arora RJSp. Transfersomes: A novel vesicular carrier for enhanced transdermal delivery of sertraline. development, characterization, and performance evaluation.,  2012, 80(4), 1061-1080.

[39]
Kavitha, K.; Bharath, N. Mani TTJRoJop, Biological, sciences C. Physical Permeation Enhancers for Transdermal Drug Delivery.,  2011, 2(4), 66.

[40]
Anushree, P; Mittal, A; Chauhan, N Alam SJJoMP, Research OP. Role of surfactants as penetration enhancer in transdermal drug delivery system, 2014.

[41]
Rai, S; Pandey, V Rai GJNr, experiments. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy. The state of the art.,  2017, 8(1), 1325708.

[42]
Alkilani, A.Z.; Nasereddin, J.; Hamed, R.; Nimrawi, S.; Hussein, G.; Abo-Zour, H.; Donnelly, R.F. Beneath the skin: A review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics,  2022, 14(6), 1152.
 [http://dx.doi.org/10.3390/pharmaceutics14061152] [PMID:  35745725]

[43]
Sapkota, R.; Dash, A.K. Liposomes and transferosomes: A breakthrough in topical and transdermal delivery. Ther. Deliv.,  2021, 12(2), 145-158.
 [http://dx.doi.org/10.4155/tde-2020-0122] [PMID:  33583219]

[44]
Chen, J; Lu, W-L; Gu, W; Lu, S-S; Chen, Z-P Cai B-CJEoodd. Skin permeation behavior of elastic liposomes: role of formulation ingredients.,  2013, 10(6), 845-856.

[45]
Duangjit, S.; Opanasopit, P.; Rojanarata, T.; Ngawhirunpat, T. Eds.; Publ, T., Eds.; Effect of edge activator on characteristic and in vitro skin permeation of meloxicam loaded in elastic liposomes; Advanced Materials Research, 2011. 
 [http://dx.doi.org/10.4028/www.scientific.net/AMR.194-196.537]

[46]
Cevc, G Blume GJBeBA-B. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force,  1992, 1104(1), 226-232.

[47]
Rajan, R; Jose, S; Mukund, VB Vasudevan DTJJoapT, Research Transferosomes-A vesicular transdermal delivery system for enhanced drug permeation.,  2011, 2(3), 138.
 [http://dx.doi.org/10.4103/2231-4040.85524]

[48]
Jain, S; Jain, P; Umamaheshwari, R Jain NJDd, pharmacy i. Transfersomes—a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation,  2003, 29(9), 1013-1026.

[49]
Benson HAJCdd. Transdermal drug delivery: penetration enhancement techniques.,  2005, 2(1), 23-33.

[50]
Björklund, S; Engblom, J; Thuresson, K Sparr EJJocr. A water gradient can be used to regulate drug transport across skin.,  2010, 143(2), 191-200.

[51]
Cevc, G; Gebauer, D; Stieber, J; Schätzlein, A Blume GJBeBA-B. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.,  1998, 1368(2), 201-215.

[52]
Chaudhary, H.; Kohli, K.; Kumar, V. Nano-transfersomes as a novel carrier for transdermal delivery. Int. J. Pharm.,  2013, 454(1), 367-380.
 [http://dx.doi.org/10.1016/j.ijpharm.2013.07.031] [PMID:  23871739]

[53]
Dhakar, R.C.J.C.; Evaluation, P. Transfersomes-a Novel Vesicular Carrier for Enhanced Transdermal Delivery of Stavudine: Development; Characterization and Performance Evaluation, 2021. 

[54]
Prajapati, S.T.; Patel, C.G.; Patel, C.N. Transfersomes: A vesicular carrier system for transdermal drug delivery. Asian J. Bio. Pharma. Res.,  2011, 2(1), 507-524.

[55]
Kumar, A. Transferosome: A recent approach for transdermal drug delivery. J. Drug Deliv. Ther.,  2018, 8(5-s), 100-104.
 [http://dx.doi.org/10.22270/jddt.v8i5-s.1981]

[56]
Bangham, A.D.; Hill, M.W.; Miller, N. Preparation and use of liposomes as models of biological membranes. Methods in membrane biology; Springer, 1974, pp. 1-68.

[57]
Singh, H.P.; Utreja, P.; Tiwary, A.K.; Jain, S. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J.,  2009, 11(1), 54-64.
 [http://dx.doi.org/10.1208/s12248-008-9078-8] [PMID:  19191031]

[58]
Abdallah, M.H. Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of nystatin; LIPOSOME & NANOTECHNOLOGY, 2013, p. 390.

[59]
Szoka, F., Jr; Papahadjopoulos, D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci.,  1978, 75(9), 4194-4198.
 [http://dx.doi.org/10.1073/pnas.75.9.4194] [PMID:  279908]

[60]
Rai, K.; Gupta, Y.; Jain, A.; Jain, S.K. Transfersomes: Self-optimizing carriers for bioactives. PDA J. Pharm. Sci. Technol.,  2008, 62(5), 362-379.
 [PMID:  19055232]

[61]
Kumar, A.; Badde, S.; Kamble, R.; Pokharkar, V.B. Development and characterization of liposomal drug delivery system for nimesulide. Int. J. Pharm. Pharm. Sci.,  2010, 2(4), 87-89.

[62]
Charcosset, C.; Juban, A.; Valour, J.P.; Urbaniak, S.; Fessi, H. Preparation of liposomes at large scale using the ethanol injection method: Effect of scale-up and injection devices. Chem. Eng. Res. Des.,  2015, 94, 508-515.
 [http://dx.doi.org/10.1016/j.cherd.2014.09.008]

[63]
Maestrelli, F.; González-Rodríguez, M.L.; Rabasco, A.M.; Mura, P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery. Int. J. Pharm.,  2006, 312(1-2), 53-60.
 [http://dx.doi.org/10.1016/j.ijpharm.2005.12.047] [PMID:  16469460]

[64]
Cevc, G.; Blume, G.; Schätzlein, A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo1Dedicated to the late Dr. Henri Ernest Bodde.1. J. Control. Release,  1997, 45(3), 211-226.
 [http://dx.doi.org/10.1016/S0168-3659(96)01566-0]

[65]
Kaur, C.D. Nimisha; Rizvi, D.A.; Fatima, Z.; Neema, Antipsoriatic and anti-inflammatory studies of Berberis aristata extract loaded nanovesicular gels. Pharmacogn. Mag.,  2017, 13(51)(Suppl. 3), 587.
 [http://dx.doi.org/10.4103/pm.pm_210_17] [PMID:  29142419]

[66]
Bnyan, R.; Khan, I.; Ehtezazi, T.; Saleem, I.; Gordon, S.; O’Neill, F.; Roberts, M. Formulation and optimisation of novel transfersomes for sustained release of local anaesthetic. J. Pharm. Pharmacol.,  2019, 71(10), 1508-1519.
 [http://dx.doi.org/10.1111/jphp.13149] [PMID:  31373700]

[67]
Planas, M.E.; Gonzalez, P.; Rodriguez, L.; Sanchez, S.; Cevc, G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg.,  1992, 75(4), 615-621.
 [http://dx.doi.org/10.1213/00000539-199210000-00027] [PMID:  1530176]

[68]
Yadav, A.R.; Mohite, S.K. Recent advances in protein and peptide drug delivery. Res. J. Pharm. Dos. Forms Technol.,  2020, 12(3), 205-212.
 [http://dx.doi.org/10.5958/0975-4377.2020.00035.X]

[69]
Leonyza, A.; Surini, S. Optimization of sodium deoxycholate-based transfersomes for percutaneous delivery of peptides and proteins. Inter. J. Applied Pharma.,  2019, 11(5), 329-332.
 [http://dx.doi.org/10.22159/ijap.2019v11i5.33615]

[70]
Paul, A.; Cevc, G.; Bachhawat, B.K. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine,  1998, 16(2-3), 188-195.
 [http://dx.doi.org/10.1016/S0264-410X(97)00185-0] [PMID:  9607029]

[71]
Xu, J.; Ding, Y.; Yang, Y. Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome. Viral Immunol.,  2008, 21(4), 483-490.
 [http://dx.doi.org/10.1089/vim.2008.0044] [PMID:  19115938]

[72]
Rattanapak, T.; Young, K.; Rades, T.; Hook, S. Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration. J. Pharm. Pharmacol.,  2012, 64(11), 1560-1569.
 [http://dx.doi.org/10.1111/j.2042-7158.2012.01535.x] [PMID:  23058043]

[73]
Garg, V; Singh, H; Bimbrawh, S; Kumar Singh, S; Gulati, M; Vaidya, Y Ethosomes and transfersomes. Principles, perspectives and practices,  2017, 14(5), 613-633.

[74]
Shamim, M.A.; Shahid, A.; Sardar, P.K.; Yeung, S.; Reyes, J.; Kim, J.; Parsa, C.; Orlando, R.; Wang, J.; Kelly, K.M.; Meyskens, F.L., Jr; Andresen, B.T.; Huang, Y. Transfersome encapsulated with the R-carvedilol enantiomer for skin cancer chemoprevention. Nanomaterials,  2023, 13(5), 929.
 [http://dx.doi.org/10.3390/nano13050929] [PMID:  36903807]

[75]
Li, Y.; Tai, Z.; Ma, J.; Miao, F.; Xin, R.; Shen, C.; Shen, M.; Zhu, Q.; Chen, Z. Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma. J. Nanobiotechnology,  2023, 21(1), 139.
 [http://dx.doi.org/10.1186/s12951-023-01877-4] [PMID:  37118807]

[76]
Khan, M.A.; Pandit, J.; Sultana, Y.; Sultana, S.; Ali, A.; Aqil, M.; Chauhan, M. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv.,  2015, 22(6), 795-802.
 [http://dx.doi.org/10.3109/10717544.2014.902146] [PMID:  24735246]

[77]
Alvi, I.A.; Madan, J.; Kaushik, D.; Sardana, S.; Pandey, R.S.; Ali, A. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells. Anticancer Drugs,  2011, 22(8), 774-782.
 [http://dx.doi.org/10.1097/CAD.0b013e328346c7d6] [PMID:  21799471]

[78]
Cronin-Fenton, D.P.; Damkier, P.; Lash, T.L. Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy. Future Oncol.,  2014, 10(1), 107-122.
 [http://dx.doi.org/10.2217/fon.13.168] [PMID:  24328412]

[79]
Sundralingam, U.; Chakravarthi, S.; Radhakrishnan, A.K.; Muniyandy, S.; Palanisamy, U.D. Efficacy of emu oil transfersomes for local transdermal delivery of 4-OH tamoxifen in the treatment of breast cancer. Pharmaceutics,  2020, 12(9), 807.
 [http://dx.doi.org/10.3390/pharmaceutics12090807] [PMID:  32854385]

[80]
Sharma, M.; Mittapelly, N.; Banala, V.T.; Urandur, S.; Gautam, S.; Marwaha, D.; Rai, N.; Singh, N.; Gupta, A.; Mitra, K.; Mishra, P.R. Amalgamated microneedle array bearing ribociclib-loaded transfersomes eradicates breast cancer via CD44 targeting. Biomacromolecules,  2022, 23(3), 661-675.
 [http://dx.doi.org/10.1021/acs.biomac.1c01076] [PMID:  34978424]

[81]
Mahmood, S.; Taher, M.; Mandal, U.K. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application. Int. J. Nanomedicine,  2014, 9, 4331-4346.
 [PMID:  25246789]

[82]
Wong, C.Y.; Martinez, J.; Dass, C.R. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J. Pharm. Pharmacol.,  2016, 68(9), 1093-1108.
 [http://dx.doi.org/10.1111/jphp.12607] [PMID:  27364922]

[83]
Easa, N.; Alany, R.G.; Carew, M.; Vangala, A. A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade. Drug Discov. Today,  2019, 24(2), 440-451.
 [http://dx.doi.org/10.1016/j.drudis.2018.11.010] [PMID:  30465877]

[84]
Padma Prashanthini, V.; Shanmugapriyan, S.; Parimala, K.; Jaikumar, S. Transferosomal gel for transdermal delivery of insulin: Formulation development and ex vivo permeation study; Intelligent Pharmacy, 2023. 

[85]
Marwah, H.; Garg, T.; Rath, G.; Goyal, A.K. Development of transferosomal gel for trans-dermal delivery of insulin using iodine complex. Drug Deliv.,  2016, 23(5), 1636-1644.
 [http://dx.doi.org/10.3109/10717544.2016.1155243] [PMID:  27187718]

[86]
Senyigit, T.; Ozer, O. Corticosteroids for skin delivery: challenges and new formulation opportunities; Glucocorticoids, 2012. 
 [http://dx.doi.org/10.5772/53909]

[87]
Cevc, G.; Blume, G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes®. Biochim. Biophys. Acta Biomembr.,  2003, 1614(2), 156-164.
 [http://dx.doi.org/10.1016/S0005-2736(03)00172-X] [PMID:  12896808]

[88]
Dhavale, R.P.; Nadaf, S.J.; Bhatia, M.S. Quantitative structure property relationship assisted development of Fluocinolone acetonide loaded transfersomes for targeted delivery. J. Drug Deliv. Sci. Technol.,  2021, 65, 102758.
 [http://dx.doi.org/10.1016/j.jddst.2021.102758]

[89]
Fesq, H.; Lehmann, J.; Kontny, A.; Erdmann, I.; Theiling, K.; Rother, M.; Ring, J.; Cevc, G.; Abeck, D. Improved risk-benefit ratio for topical triamcinolone acetonide in TransfersomeR in comparison with equipotent cream and ointment: A randomized controlled trial. Br. J. Dermatol.,  2003, 149(3), 611-619.
 [http://dx.doi.org/10.1046/j.1365-2133.2003.05475.x] [PMID:  14510997]

[90]
Cevc, G.; Blume, G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim. Biophys. Acta Biomembr.,  2004, 1663(1-2), 61-73.
 [http://dx.doi.org/10.1016/j.bbamem.2004.01.006] [PMID:  15157608]

[91]
Sahu, A.N.; Mohapatra, D. Nanovesicular transferosomes for the topical delivery of plant bioactives; Future Medicine, 2021, pp. 2491-2495.

[92]
Manasa, R.; Shivananjappa, M. Delivering Herbal Drugs Using Nanotechnology; Advances in Novel Formulations for Drug Delivery, 2023, pp. 449-472.

[93]
Abdallah, M.; Neseem, D.; Elgazayerly, O.N.; Abdelbary, A.A. Topical delivery of quercetin loaded transfersomes for wound treatment: In vitro and in vivo evaluation. Inter. J. App. Pharma.,  2021, 13(5), 189-197.
 [http://dx.doi.org/10.22159/ijap.2021v13i5.41345]

[94]
Prouillet, C.; Mazière, J.C.; Mazière, C.; Wattel, A.; Brazier, M.; Kamel, S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem. Pharmacol.,  2004, 67(7), 1307-1313.
 [http://dx.doi.org/10.1016/j.bcp.2003.11.009] [PMID:  15013846]

[95]
Derakhshanian, H.; Djalali, M.; Djazayery, A.; Nourijelyani, K.; Ghadbeigi, S.; Pishva, H.; Saedisomeolia, A.; Bahremand, A.; Dehpour, A.R. Quercetin prevents experimental glucocorticoid-induced osteoporosis: A comparative study with alendronate. Can. J. Physiol. Pharmacol.,  2013, 91(5), 380-385.
 [http://dx.doi.org/10.1139/cjpp-2012-0190] [PMID:  23656499]

[96]
Pandit, A.P.; Omase, S.B.; Mute, V.M. A chitosan film containing quercetin-loaded transfersomes for treatment of secondary osteoporosis. Drug Deliv. Transl. Res.,  2020, 10(5), 1495-1506.
 [http://dx.doi.org/10.1007/s13346-020-00708-5] [PMID:  31942700]

[97]
Isemura, M. Catechin in human health and disease. Molecules,  2019, 24(3), 528.
 [http://dx.doi.org/10.3390/molecules24030528] [PMID:  30717121]

[98]
Hsieh, W.C.; Fang, C.W.; Suhail, M.; Lam Vu, Q.; Chuang, C.H.; Wu, P.C. Improved skin permeability and whitening effect of catechin-loaded transfersomes through topical delivery. Int. J. Pharm.,  2021, 607, 121030.
 [http://dx.doi.org/10.1016/j.ijpharm.2021.121030] [PMID:  34438007]

[99]
Payne, R. Limitations of NSAIDs for pain management: Toxicity or lack of efficacy? J. Pain,  2000, 1(3)(Suppl.), 14-18.
 [http://dx.doi.org/10.1054/jpai.2000.16611] [PMID:  14622838]

[100]
Machado, G.C.; Abdel-Shaheed, C.; Underwood, M.; Day, R.O. Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain. BMJ,  2021, 372(104), n104.
 [http://dx.doi.org/10.1136/bmj.n104] [PMID:  33514562]

[101]
Khan, MI; Yaqoob, S; Madni, A; Akhtar, MF; Sohail, MF Saleem, A Development and in vitro/ex vivo evaluation of lecithin-based deformable transfersomes and transfersome-based gels for combined dermal delivery of meloxicam and dexamethasone. BioMed Research International,  2022, 2022

[102]
Dudhipala, N.; Phasha Mohammed, R.; Adel Ali Youssef, A.; Banala, N. Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application: in vitro and ex vivo skin permeation. Drug Dev. Ind. Pharm.,  2020, 46(8), 1334-1344.
 [http://dx.doi.org/10.1080/03639045.2020.1788069] [PMID:  32598194]

[103]
Vanaja, K.S.S.; Murthy, S.N.; Shivakumar, H.N. Iontophoretic mediated intraarticular delivery of deformable liposomes of diclofenac sodium. Curr. Drug Deliv.,  2021, 18(4), 421-432.
 [http://dx.doi.org/10.2174/1567201817666201014144708] [PMID:  33059549]

[104]
Yuan, M.; Niu, J.; Xiao, Q.; Ya, H.; Zhang, Y.; Fan, Y.; Li, L.; Li, X. Hyaluronan-modified transfersomes based hydrogel for enhanced transdermal delivery of indomethacin. Drug Deliv.,  2022, 29(1), 1232-1242.
 [http://dx.doi.org/10.1080/10717544.2022.2053761] [PMID:  35403516]

[105]
Brown, A.K.; Christo, P.J.; Wu, C.L. Strategies for postoperative pain management. Baillieres. Best Pract. Res. Clin. Anaesthesiol.,  2004, 18(4), 703-717.
 [http://dx.doi.org/10.1016/j.bpa.2004.05.004] [PMID:  15460554]

[106]
Power, I.; Barratt, S. Analgesic agents for the postoperative period. Nonopioids. Surg. Clin. North Am.,  1999, 79(2), 275-295.
 [http://dx.doi.org/10.1016/S0039-6109(05)70383-2] [PMID:  10352655]

[107]
Hartrick, C.T. Tapentadol immediate release for the relief of moderate-to-severe acute pain. Expert Opin. Pharmacother.,  2009, 10(16), 2687-2696.
 [http://dx.doi.org/10.1517/14656560903313734] [PMID:  19795998]

[108]
Patil, P.; Nene, S.; Shah, S.; Singh, S.B.; Srivastava, S. Exploration of novel drug delivery systems in topical management of osteoarthritis. Drug Deliv. Transl. Res.,  2023, 13(2), 531-546.
 [http://dx.doi.org/10.1007/s13346-022-01229-z] [PMID:  36031671]

[109]
Deng, P.; Athary Abdulhaleem, M. F.; Masoud, R.E.; Alamoudi, W.M.; Zakaria, M.Y. “Employment of PEGylated ultra-deformable transferosomes for transdermal delivery of tapentadol with boosted bioavailability and analgesic activity in post-surgical pain”. Int. J. Pharm.,  2022, 628, 122274.
 [http://dx.doi.org/10.1016/j.ijpharm.2022.122274] [PMID:  36228884]

[110]
Giudice, E.; Campbell, J. Needle-free vaccine delivery. Adv. Drug Deliv. Rev.,  2006, 58(1), 68-89.
 [http://dx.doi.org/10.1016/j.addr.2005.12.003] [PMID:  16564111]

[111]
Kupper, T.S.; Fuhlbrigge, R.C. Immune surveillance in the skin: Mechanisms and clinical consequences. Nat. Rev. Immunol.,  2004, 4(3), 211-222.
 [http://dx.doi.org/10.1038/nri1310] [PMID:  15039758]

[112]
Kaurav, M.; Minz, S.; Sahu, K.; Kumar, M.; Madan, J.; Pandey, R.S. Nanoparticulate mediated transcutaneous immunization: Myth or reality. Nanomedicine,  2016, 12(4), 1063-1081.
 [http://dx.doi.org/10.1016/j.nano.2015.12.372] [PMID:  26767517]

[113]
Teunissen, M; Kapsenberg, M; Bos, J Langerhans cells and related skin dendritic cells. Skin immune system,  1997, 2

[114]
Choi, M.J.; Maibach, H.I. Topical vaccination of DNA antigens: topical delivery of DNA antigens. Skin Pharmacol. Physiol.,  2003, 16(5), 271-282.
 [http://dx.doi.org/10.1159/000072067] [PMID:  12907832]

[115]
Mishra, D.; Dubey, V.; Asthana, A.; Saraf, D.; Jain, N. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine,  2006, 24(22), 4847-4855.
 [http://dx.doi.org/10.1016/j.vaccine.2006.03.011] [PMID:  16600441]

[116]
Wang, J.; Hu, J.; Li, F.; Liu, G.; Zhu, Q.; Liu, J.; Ma, H.; Peng, C.; Si, F. Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA–cationic deformable liposome complex. Exp. Dermatol.,  2007, 16(9), 724-729.
 [http://dx.doi.org/10.1111/j.1600-0625.2007.00584.x] [PMID:  17697144]

[117]
Mahor, S.; Rawat, A.; Dubey, P.; Gupta, P.; Khatri, K.; Goyal, A.; Vyas, S. Cationic transfersomes based topical genetic vaccine against hepatitis B. Int. J. Pharm.,  2007, 340(1-2), 13-19.
 [http://dx.doi.org/10.1016/j.ijpharm.2007.03.006] [PMID:  17446015]

[118]
Gupta, P.N.; Mishra, V.; Singh, P.; Rawat, A.; Dubey, P.; Mahor, S.; Vyas, S.P. Tetanus toxoid-loaded transfersomes for topical immunization. J. Pharm. Pharmacol.,  2010, 57(3), 295-301.
 [http://dx.doi.org/10.1211/0022357055515] [PMID:  15807984]

[119]
Gupta, P.N.; Mishra, V.; Rawat, A.; Dubey, P.; Mahor, S.; Jain, S.; Chatterji, D.P.; Vyas, S.P. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: A comparative study. Int. J. Pharm.,  2005, 293(1-2), 73-82.
 [http://dx.doi.org/10.1016/j.ijpharm.2004.12.022] [PMID:  15778046]

[120]
Kamboj, S.; Saini, V.; Magon, N.; Bala, S.; Jhawat, V. Vesicular drug delivery systems: A novel approach for drug targeting. Int. J. Drug Deliv.,  2013, 5(2), 121-130.

[121]
Li, J.; Wang, Y.; Liang, R.; An, X.; Wang, K.; Shen, G.; Tu, Y.; Zhu, J.; Tao, J. Recent advances in targeted nanoparticles drug delivery to melanoma. Nanomedicine,  2015, 11(3), 769-794.
 [http://dx.doi.org/10.1016/j.nano.2014.11.006] [PMID:  25555352]

[122]
Jangdey, M.S.; Kaur, C.D.; Saraf, S. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma. Artif. Cells Nanomed. Biotechnol.,  2019, 47(1), 904-916.
 [http://dx.doi.org/10.1080/21691401.2019.1578784] [PMID:  30856018]

[123]
Manconi, M.; Manca, M.L.; Caddeo, C.; Valenti, D.; Cencetti, C.; Diez-Sales, O.; Nacher, A.; Mir-Palomo, S.; Terencio, M.C.; Demurtas, D.; Gomez-Fernandez, J.C.; Aranda, F.J.; Fadda, A.M.; Matricardi, P. Nanodesign of new self-assembling core-shell gellan-transfersomes loading baicalin and in vivo evaluation of repair response in skin. Nanomedicine,  2018, 14(2), 569-579.
 [http://dx.doi.org/10.1016/j.nano.2017.12.001] [PMID:  29248674]

[124]
Conaghan, P.G.; Dickson, J.; Bolten, W.; Cevc, G.; Rother, M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology,  2013, 52(7), 1303-1312.
 [http://dx.doi.org/10.1093/rheumatology/ket133] [PMID:  23542612]

[125]
Rother, M.; Conaghan, P.G. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J. Rheumatol.,  2013, 40(10), 1742-1748.
 [http://dx.doi.org/10.3899/jrheum.130192] [PMID:  23996292]

[126]
Piumitali, B.; Neeraj, U.; Jyotivardhan, J. Transfersomes—a nanoscience in transdermal drug delivery and its clinical advancements. Int. J. Nanosci.,  2020, 19(4), 1950033.
 [http://dx.doi.org/10.1142/S0219581X19500339]

[127]
Seidel, E.J.; Rother, M.; Regenspurger, K.; Rother, I. A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome ® gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise. J. Sports Sci.,  2016, 34(1), 88-95.
 [http://dx.doi.org/10.1080/02640414.2015.1035667] [PMID:  25893979]

[128]
Rother, M.; Vester, J.; Bolten, W.W.; Kneer, W.; Conaghan, P.G. Meta-analysis of randomized clinical trials investigating the effect of tdt 064, a gel-based formulation containing ultra-deformable phospholipid vesicles, in patients with knee osteoarthritis. Rheumatology. Rheumatology,  2014, 4(2), 1-7.
 [http://dx.doi.org/10.4172/2161-1149.1000138]

[129]
Sigurgeirsson, B.; Ghannoum, M. Therapeutic potential of TDT 067 (terbinafine in Transfersome®): A carrier-based dosage form of terbinafine for onychomycosis. Expert Opin. Investig. Drugs,  2012, 21(10), 1549-1562.
 [http://dx.doi.org/10.1517/13543784.2012.711315] [PMID:  22876754]

[130]
Dominicus, R.; Weidner, C.; Tate, H.; Kroon, H.A. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis. Br. J. Dermatol.,  2012, 166(6), 1360-1362.
 [http://dx.doi.org/10.1111/j.1365-2133.2011.10766.x] [PMID:  22136723]

[131]
Ghannoum, M.; Isham, N.; Henry, W.; Kroon, H.A.; Yurdakul, S. Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo. Antimicrob. Agents Chemother.,  2012, 56(5), 2530-2534.
 [http://dx.doi.org/10.1128/AAC.05998-11] [PMID:  22354309]

[132]
Reddy, Y.D.; Sravani, A.; Ravisankar, V.; Prakash, P.R.; Reddy, Y.S.R.; Bhaskar, N.V. Transferosomes a novel vesicular carrier for transdermal drug delivery system. J. Innov. Pharm. Biol. Sci.,  2015, 2(2), 193-208.

[133]
Estupiñan, O.R.; Garcia-Manrique, P.; Blanco-Lopez, M.C.; Matos, M.; Gutiérrez, G. Vitamin D3 loaded niosomes and transfersomes produced by ethanol injection method: identification of the critical preparation step for size control. Foods,  2020, 9(10), 1367.
 [http://dx.doi.org/10.3390/foods9101367] [PMID:  32993064]

[134]
Bhardwaj, V.; Shukla, V.; Singh, A.; Malviya, R.; Sharma, P. Transfersomes ultra flexible vesicles for transdermal delivery. Int. J. Pharm. Sci. Res.,  2010, 1(3), 12-20.

[135]
Kumavat, SD; Chaudhari, YS; Borole, P; Duvvuri, P; Bubera, N; Shenghani, K Transfersomes: A promising approach for transdermal drug delivery system. Asian J. pharma. sci. res.,  2013, 3(5), 1-17.

[136]
Nayak, S.S.; Jangde, R.K. Formulation and design optimization of repaglinide loaded transferosomes for management of type II diabetes mellitus. National J. Pharma. Sci.,  2023, 3(1), 115-125.
 [http://dx.doi.org/10.22271/27889262.2023.v3.i1b.76]

[137]
Ghanbarzadeh, S.; Arami, S. Formulation and evaluation of piroxicam transferosomal gel: An approach for penetration enhancement. J. Drug Deliv. Sci. Technol.,  2013, 23(6), 587-590.
 [http://dx.doi.org/10.1016/S1773-2247(13)50089-X]

[138]
Patel, B.J.; Patel, J.L. Design and development of transferosome of fluconazole for topical drug delivery system. Pharma Sci. Monitor,  2014, 5.

[139]
Abdallah, M.H.; Abu Lila, A.S.; Shawky, S.M.; Almansour, K.; Alshammari, F.; Khafagy, E.S.; Makram, T.S. Experimental design and optimization of nano-transfersomal gel to enhance the hypoglycemic activity of silymarin. Polymers,  2022, 14(3), 508.
 [http://dx.doi.org/10.3390/polym14030508] [PMID:  35160498]

[140]
Ramkanth, S.; Anitha, P.; Gayathri, R.; Mohan, S.; Babu, D. Formulation and design optimization of nano-transferosomes using pioglitazone and eprosartan mesylate for concomitant therapy against diabetes and hypertension. Eur. J. Pharm. Sci.,  2021, 162, 105811.
 [http://dx.doi.org/10.1016/j.ejps.2021.105811] [PMID:  33757828]

[141]
Patel, R; Singh, S; Singh, S; Sheth, N; Gendle, R Development and characterization of curcumin loaded transfersome for transdermal delivery. J. pharma. sci. res.,  2009, 1(>4), 71.

[142]
Sundralingam, U.; Muniyandy, S.; Radhakrishnan, A.K.; Palanisamy, U.D. Ratite oils for local transdermal therapy of 4-OH tamoxifen: development, characterization, and ex vivo evaluation. J. Liposome Res.,  2021, 31(3), 217-229.
 [http://dx.doi.org/10.1080/08982104.2020.1777155] [PMID:  32648792]

[143]
Maurya, S.D.; Aggarwal, S.; Tilak, V.K.; Dhakar, R.C.; Singh, A.; Maurya, G. Enhanced transdermal delivery of indinavir sulfate via transfersomes. Pharm. Glob. (IJCP),  2010, 1(06)

[144]
Ahad, A.; Aqil, M.; Kohli, K.; Sultana, Y.; Mujeeb, M.; Ali, A. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine,  2012, 8(2), 237-249.
 [http://dx.doi.org/10.1016/j.nano.2011.06.004] [PMID:  21704600]

[145]
Balata, G.F.; Faisal, M.M.; Elghamry, H.A.; Sabry, S.A. Preparation and characterization of ivabradine HCl transfersomes for enhanced transdermal delivery. J. Drug Deliv. Sci. Technol.,  2020, 60, 101921.
 [http://dx.doi.org/10.1016/j.jddst.2020.101921]

[146]
Zheng, W.; Fang, X.; Wang, L.; Zhang, Y. Preparation and quality assessment of itraconazole transfersomes. Int. J. Pharm.,  2012, 436(1-2), 291-298.
 [http://dx.doi.org/10.1016/j.ijpharm.2012.07.003] [PMID:  22796030]

[147]
Qushawy, M.; Nasr, A.; Abd-Alhaseeb, M.; Swidan, S. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics,  2018, 10(1), 26.
 [http://dx.doi.org/10.3390/pharmaceutics10010026] [PMID:  29473897]
Rights & Permissions Print Cite
Article Metrics
44
1
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/0115672018272012231213100535	Print ISSN 1567-2018
Publisher Name Bentham Science Publisher	Online ISSN 1875-5704
Current Drug Delivery

Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications

Abstract

Graphical Abstract

Related Journals

Related Books

Related Articles
